{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T23:15:51Z","timestamp":1770938151330,"version":"3.50.1"},"reference-count":85,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Chemotherapy"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1179\/joc.2010.22.5.291","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T13:06:20Z","timestamp":1389272780000},"page":"291-297","source":"Crossref","is-referenced-by-count":9,"title":["Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)"],"prefix":"10.1080","volume":"22","author":[{"given":"B.","family":"Butorac-Petanjek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Popovi\u0107-Grle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2013,11,29]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"349","article-title":"Alternative projections of mortality and disabil-ity by cause 1990-2020: Global burden of disease study","volume":"1997","author":"Murray CJ","year":"1504","unstructured":"Murray CJ, Lopez AD. Alternative projections of mortality and disabil-ity by cause 1990-2020: Global burden of disease study. Lancet 1997; 349: 1498-1504.","journal-title":"Lancet"},{"key":"e_1_2_1_3_1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease 2005. Global strategy for the diagnosis management and prevention of chronic obstruc-tive pulmonary disease: executive summary. National Heart Lung and Blood Institute \/ World Health Organization. Available at www.goldcopd.com. Up-dated November 2008."},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401422101"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.252784499"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200408-039MS"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200504030-00001"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.2306024"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-106-2-196"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1183\/18106838.0303.250","article-title":"Causes and management of exacerba-tions of COPD","volume":"3","author":"Vijayasaratha K","year":"2007","unstructured":"Vijayasaratha K, Stockley RA. Causes and management of exacerba-tions of COPD. Breathe 2007; 3: 251\u2013263.","journal-title":"Breathe"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200707-088ET"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200707-101TH"},{"issue":"554","key":"e_1_2_1_13_1","first-page":"13","article-title":"Exacerbations of chronic obstruc-tive pulmonary disease","volume":"4","author":"Anzueto A","year":"2007","unstructured":"Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstruc-tive pulmonary disease. Proc Am Thorac Soc 2007; 4: 554-564. 13","journal-title":"Proc Am Thorac Soc"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.1992.11701168"},{"key":"e_1_2_1_15_1","first-page":"1204","article-title":"Exacerbation of chronic obstructive pul-monary disease","volume":"48","author":"Wedzicha JA","year":"2003","unstructured":"Wedzicha JA, Donaldson GC. Exacerbation of chronic obstructive pul-monary disease. Respir Care 2003; 48: 1204\u20131213.","journal-title":"Respir Care"},{"key":"e_1_2_1_16_1","first-page":"274: 1852","article-title":"Hospital and 1-year sur-vival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease","volume":"1995","author":"Seneff MG","unstructured":"Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year sur-vival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-1857.","journal-title":"JAMA"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00024804"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1183\/09058180.05.00009404"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.2.317"},{"key":"e_1_2_1_20_1","first-page":"729","volume":"101","author":"Tumkaya M","year":"2007","unstructured":"Tumkaya M, Atis S, Ozge C et al. Relationship between airway colo-nization, inflammation and exacerbation frequency in COPD. Respir Med. 2007; 101: 729\u2013737.","journal-title":"Relationship between airway colo-nization, inflammation and exacerbation frequency in COPD. Respir Med"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200603-059MS"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.45.4.276"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00109906"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.6.1638"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.163.2.2003122"},{"key":"e_1_2_1_26_1","first-page":"358","article-title":"Connett JE for the Lung Health Study Research Group","volume":"164","author":"Kanner RE","year":"2001","unstructured":"Kanner RE, Anthonisen NR, Connett JE for the Lung Health Study Research Group. Lower respiratory illnesses promote FEV1 decline in cur-rent smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 358\u2013364.","journal-title":"Lower respiratory illnesses promote FEV1 decline in cur-rent smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.57.10.847"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-007-6078-z"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9932"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.1.101"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.1.252-262.2001"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219100-00005"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5361.295"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/648404"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","unstructured":"Juan C Gutierrez O Renom F at al. Chronic respiratory infections by mucoid carbapenemase-producing Pseudomonas aeruginosa strains a new potential public health problem. Antimicrob Agents Chemother 2008; 52 (6): 2285-2286.","DOI":"10.1128\/AAC.00076-08"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.05324-0"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00322.2004"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2004-0276OC"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmm.2006.05.003"},{"issue":"02","key":"e_1_2_1_40_1","first-page":"2009","article-title":"Alberta Clinical Guidelineworkinggroup.Updated2006.http:\/\/www.topalbertadoctors.org\/PDF\/complete set\/Bronchitis\/ AE-COPD_guideline","volume":"17","author":"Guideline for The Management of Acute Exacerbation of Chronic Ob-structive Pulmonary Diseases (AECOPD","year":"2000","unstructured":"Guideline for The Management of Acute Exacerbation of Chronic Ob-structive Pulmonary Diseases (AECOPD) 2000. Alberta Clinical Guidelineworkinggroup.Updated2006.http:\/\/www.topalbertadoctors.org\/PDF\/complete set\/Bronchitis\/ AE-COPD_guideline.pdf (last viewed 17.02.2009)","journal-title":"pdf (last viewed"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.923-927.2006"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.2.818-823.2004"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012561"},{"key":"e_1_2_1_44_1","first-page":"3366","volume":"74","author":"Fernaays MM","year":"2006","unstructured":"Fernaays MM, Lesse AJ, Sethi S et al. Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary disease. Infect Immun 2006; 74: 3366\u20133374.","journal-title":"Differential genome contents of nontypeable Haemophilus influenzae strains from adults with chronic obstructive pulmonary disease. Infect Immun"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200709-1413OC"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00055705"},{"key":"e_1_2_1_47_1","first-page":"661","article-title":"Acute exacerbation of chronic bronchitis: a primary care consensus guideline","volume":"10","author":"Brunton S","year":"2004","unstructured":"Brunton S, Carmichael BP, Colgan R, et al. Acute exacerbation of chronic bronchitis: a primary care consensus guideline. Am J Manag Care 2004; 10: 661\u2013662.","journal-title":"Am J Manag Care"},{"key":"e_1_2_1_48_1","first-page":"442","volume":"62","author":"Falagas ME","year":"2008","unstructured":"Falagas ME, Avgeri SG, Matthaiou DK et al. Short-versus long-dura-tion antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother 2008; 62: 442\u2013450.","journal-title":"Matthaiou DK et al. Short-versus long-dura-tion antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother"},{"issue":"10","key":"e_1_2_1_49_1","first-page":"1059","article-title":"at al","volume":"302","author":"Schuetz P","year":"2009","unstructured":"Schuetz P, Christ-Crain M, Thomann R, at al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomised controlled trial. JAMA 2009; 302 (10): 1059\u20131066.","journal-title":"Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomised controlled trial. JAMA"},{"key":"e_1_2_1_50_1","first-page":"163","volume":"7","author":"Larsson L","year":"1998","unstructured":"Larsson L, Lode H, Rollof J. Use of antibiotics, antioxidants, mu-colytics and vaccines in the therapy of chronic obstructive pulmonary disease. In: Postma DS, Siafakas NM, editors. Management of chronic obstructive pulmonary disease. Eur Respir Mon 1998; 7: 163\u2013168.","journal-title":"Use of antibiotics, antioxidants, mu-colytics and vaccines in the therapy of chronic obstructive pulmonary disease"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.11.7.911"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.117.3.662"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.07-0149"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwj021"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0702377104"},{"key":"e_1_2_1_56_1","doi-asserted-by":"crossref","unstructured":"Harrison CJ Woods C Stout G et al. Susceptibilities of Haemophilus influenzae Streptococcus pneumoniae including serotype 19A and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics. J Antimicrob Chemother 2009; 63 (3);511-519.","DOI":"10.1093\/jac\/dkn538"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.07.035"},{"key":"e_1_2_1_58_1","volume":"9","author":"Vila-Corcoles A","year":"2009","unstructured":"Vila-Corcoles A, Bejarano-Romero F, Salsench E. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. MBC Infect Dis 2009; 9: 36. Im\u00f6hl M, Rene Reinert R, van der Linden M. Serotype-specific peni-cillin resistance of Streptococcus pneumoniae in Germany from 1992 to 2008. Int J Med Microbiol 2010; (Epub ahed of print)","journal-title":"Int J Med Microbiol"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2007.19.5.500"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.07.017"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1586\/14787210.4.3.405"},{"issue":"1","key":"e_1_2_1_62_1","first-page":"1","article-title":"Immuno-modulation and anti-inflammatory benefits of an-tibiotics: The example of tilmicosin","volume":"74","author":"Buret AG","year":"2010","unstructured":"Buret AG. Immuno-modulation and anti-inflammatory benefits of an-tibiotics: The example of tilmicosin. Can J Vet Res 2010; 74 (1): 1\u201310.","journal-title":"Can J Vet Res"},{"key":"e_1_2_1_63_1","doi-asserted-by":"publisher","DOI":"10.1086\/428058"},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcp.0000245711.43891.16"},{"key":"e_1_2_1_65_1","first-page":"209","article-title":"0, Erakovi V, Parnham MJ","volume":"429","author":"Illi","year":"2001","unstructured":"Illi 0, Erakovi V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001; 429: 209\u2013229.","journal-title":"Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.12.1.5"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2008.01.010"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1D634"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.2165\/00151829-200403010-00007"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2004.06.009"},{"key":"e_1_2_1_71_1","first-page":"132","article-title":"uli 0, Erakovi V, at al","volume":"517","author":"Parnham MJ","year":"2005","unstructured":"Parnham MJ, uli 0, Erakovi V, at al. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. Eur J Pharmacol 2005; 517: 132\u2013143.","journal-title":"Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment. Eur J Pharmacol"},{"key":"e_1_2_1_72_1","unstructured":"Blasi F Bonardi D Aliberti S et al. Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy. Pulm Pharmacol Ther doi: 10.10164pupt.2009.12.002"},{"key":"e_1_2_1_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01396.x"},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2002.14.1.3"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.056374"},{"key":"e_1_2_1_76_1","doi-asserted-by":"crossref","unstructured":"Wood-Baker RR Gibson PG Hannay M et al. Systemic corticos-teroids for acute exacerbations of chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2005; Issue 1. Art. No.: CD001288. pub2. DOI: 10.1002\/14651858 .CD001288.pub2","DOI":"10.1002\/14651858.CD001288.pub2"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)11326-0"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1080\/15412550600830263"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00014304"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.120.1.258"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1094-5539(03)00105-6"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S1758"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-1385"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.2147\/copd.s12159945"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1159\/000107059"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200504-025SR"}],"container-title":["Journal of Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1179\/joc.2010.22.5.291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T22:19:34Z","timestamp":1770934774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1179\/joc.2010.22.5.291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1179\/joc.2010.22.5.291"],"URL":"https:\/\/doi.org\/10.1179\/joc.2010.22.5.291","relation":{},"ISSN":["1120-009X","1973-9478"],"issn-type":[{"value":"1120-009X","type":"print"},{"value":"1973-9478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}